Clinical Trial Update: Study Evaluating PEG-G-CSF Injectionin Preventing Neutropenia After Chemotherapy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating a PEG-G-CSF injection to prevent chemotherapy-induced neutropenia, with status listed as active but not recruiting, in female …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Chemotherapy-induced Febrile Neutropenia

Drugs mentioned

• PEG-G-CSF Injection (pegfilgrastim)

Snippet

Sponsor: Kexing Biopharm Co., Ltd. | Conditions: Neutropenia, Chemotherapy-Induced Febrile, Breast Neoplasm Female | Phase 3 | Status: ACTIVE_NOT_RECRUITING